The biology of Epstein-Barr virus in post-transplant lymphoproliferative disease (Q34294857)

1 August 2017

1 reference

title

The biology of Epstein-Barr virus in post-transplant lymphoproliferative disease (English)

1 reference

1 August 2017

0 references

Hsieh WS

1

1 reference

PubMed ID

11428990

1 August 2017

Lemas MV

series ordinal

2

1 reference

PubMed ID

11428990

1 August 2017

Ambinder RF

series ordinal

3

1 reference

1 August 2017

1 September 1999

1 reference

Transplant Infectious Disease

1 August 2017

1 reference

1 August 2017

1

1 reference

1 August 2017

3

1 reference

1 August 2017

204-212

1 reference

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

1 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

In situ detection of lytic Epstein-Barr virus infection: expression of the NotI early gene and viral interleukin-10 late gene in clinical specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

Comparison of EBV neutralization tests based on abortive infection or transformation of lymphoid cells and their relation to membrane reactive antibodies (anti-MA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

Post‐transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

Treatment of organ transplant-related lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

Hodgkin's disease following solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treated virus carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

Cytotoxic T lymphocyte responses to Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

Concatameric replication of Epstein-Barr virus: structure of the termini in virus-producer and newly transformed cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

1 reference

7 January 2021

Hodgkin's disease after transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

7 January 2021

Lymphomas and lymphoproliferative lesions developing under cyclosporin therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

7 January 2021

Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

7 January 2021

Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

7 January 2021

Durable remission after aggressive chemotherapy for post-cardiac transplant lymphoproliferation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

7 January 2021

Differences in T-cell-receptor gene rearrangement and transcription in nasal lymphomas of natural killer and T-cell types: implications on cellular origin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010308.X

7 January 2021

10.1034/J.1399-3062.1999.010308.X

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11428990